Tic Flare-Ups and Days When Symptoms Get Worse

Share this post:

LinkedIn
Facebook
X
Reddit
WhatsApp
Print

Article title Tic Flare-Ups and Days When Symptoms Get Worse
SEO title Tic Flare-Ups | Support for Days When Tics Get Worse
Meta description Learn why tics may increase, how to track patterns, how to reduce pressure and which changes should be discussed with a clinician.
URL slug /tic-flare-ups/
Recommended length Supporting, 2,000 to 2,600 words because readers often arrive worried and need clear next steps
Suggested word count 2,400
Reason to exist Supports “tics getting worse” searches and reduces fear without giving medical advice.

Medical review needed before publication
Reviewed by [qualified clinician, researcher or medical editor]
Last reviewed [add date after medical review]

Tic Flare-Ups and Days When Symptoms Get Worse

A tic flare-up is a period when tics become more frequent, stronger, louder, more painful or harder to manage. Flare-ups can happen with Tourette syndrome and other tic disorders because tics often rise and fall over time. Stress, fatigue, illness, excitement, pressure to suppress tics, school demands, work demands and body discomfort may all play a role. The National Institute of Neurological Disorders and Stroke (NINDS) states that tics are often worse with excitement or anxiety and may improve during calm, focused activities. (NINDS)

Fast answer on flare-ups

Tics can get worse for a day, a week or a longer period without meaning that something dangerous is happening. A flare-up can involve motor tics, vocal tics or both. You may notice more blinking, shoulder shrugging, head jerking, touching, tapping, sniffing, throat clearing, humming, words or phrases.

A flare-up can also change the way tics feel. Urges may feel stronger. Suppressing tics may feel harder. Pain may build faster. A child may tic more after school. A teen may have more tics around tests or social events. An adult may notice more tics after meetings, poor sleep or illness.

The first step is to reduce pressure around symptoms. You can pause the task, take a break, move to a quieter setting, lower demands for a short period and ask what support is needed. If tics cause pain, injury, school issues, work issues, social strain or stress, CDC says behavioral treatment and medication may help. (CDC)

A flare-up needs prompt medical review when symptoms are sudden and severe, cause injury, affect breathing or eating, involve loss of awareness, come with weakness, fever, severe headache, confusion or seizure like events or appear after medication changes.

Normal tic waxing and waning

Tics often wax and wane. This means symptoms can rise, fall, shift and return across days, weeks and months. A blinking tic may fade, then a neck tic may appear. A throat clearing tic may get louder during one period, then become quieter later. A movement tic may feel harder during one week and easier the next.

This pattern can confuse families because it may look like the person can control symptoms. A child may tic less at school, then tic more at home. An adult may suppress tics during a meeting, then have stronger symptoms later. Suppression can take effort and can leave the person tired.

CDC describes tics as sudden twitches, movements or sounds that people do repeatedly, and explains that people with tics cannot simply stop their body from doing them. (CDC) This helps explain why a flare-up should not be treated as misbehavior.

Waxing and waning also means that a short bad period should be viewed in context. A few harder days may call for rest, tracking and reduced pressure. A lasting change, pain, injury or major daily disruption should be discussed with a qualified healthcare professional.

Stress, fatigue and illness

Stress can raise tic intensity for many people. Exams, conflict, work deadlines, public attention, social pressure and fear of ticcing can all add strain. Tics may also rise after a person spends a long time trying not to tic.

Fatigue can make tics harder to manage. Poor sleep can reduce patience, increase body tension and make it harder to use coping skills. A child who holds tics in during class may come home tired and tic more. An adult who stays composed during work may have stronger symptoms later.

Illness can also affect symptoms. A cold, fever, sore throat, headache, body pain, allergies or stomach discomfort can increase body strain. A throat clearing tic may feel worse during throat irritation. A blinking tic may feel worse when the eyes are dry or irritated.

NINDS notes that certain physical experiences can trigger or worsen tics. (NINDS) If a symptom could be a tic or a medical issue, ask a clinician. Sniffing can be a vocal tic, but it can also come from allergies. Coughing can be a tic, but it can also come from asthma, infection or reflux. Eye blinking can be a tic, but it can also come from eye irritation.

School or work pressure

School and work often create tic pressure because both settings require sitting still, staying quiet, following schedules and managing other people’s reactions. Those demands can make a flare-up harder to handle.

A child may tic more during tests, reading, handwriting, long classes, transitions or after being corrected. A vocal tic may draw attention in a quiet classroom. A motor tic may make writing slower. A student may suppress tics all day and then have a strong flare at home.

School support may include the following.

  • Short breaks
  • Quiet test space
  • Extra time when tics interrupt work
  • Typed assignments
  • Permission to leave class briefly
  • A discreet signal with a teacher
  • Staff education about tics
  • A response plan for teasing, copying or filming

Adults may notice flare-ups during meetings, phone calls, presentations, long computer sessions, client contact, driving or shared quiet spaces. Work support may include brief breaks, meeting flexibility, written follow up, seating choice, camera or microphone flexibility during virtual meetings and ergonomic changes when motor tics cause pain.

Support should focus on the task that becomes harder. If tics affect writing, address writing. If vocal tics affect calls, address calls. If tics cause pain, address pain and posture.

Medication or care changes to discuss

A sudden increase in tics should be discussed with a clinician when it follows a medication change, missed doses, new supplements, substance use or a change in medical care. You should not stop, start or change medication without medical guidance.

Some people take medication for tics. Others take medication for ADHD, OCD, anxiety, mood symptoms, sleep or other health needs. Medication changes can affect sleep, anxiety, attention, restlessness or body sensations. A clinician can review what changed and what to do next.

A flare-up can also happen when therapy routines change. If you are using CBIT skills and symptoms rise, discuss the pattern with your provider. You may need to adjust which tic you are working on, review competing responses or reduce pressure during practice.

CDC states that treatment may include behavioral treatment or medication when tics interfere with life, and that related conditions such as ADHD or OCD may also need treatment. (CDC) A care plan should review both tics and related symptoms when flare-ups keep returning.

Support at home

Home support during a tic flare-up should reduce pressure and protect dignity. A flare-up is not a time for repeated correction. It is a time to ask what helps, check for pain and lower demands for a short period when needed.

Helpful home steps can include the following.

  • Pause the current task
  • Offer a short break
  • Move to a quieter space
  • Ask if anything hurts
  • Avoid comments on every tic
  • Keep routines steady when possible
  • Reduce pressure after school or work
  • Give the person time to reset after suppression

For children, use calm words. You might ask, “Does anything hurt?” or “Do you need a break?” Avoid saying “stop it” or “control yourself.” A child may already be trying hard.

For teens, privacy matters. They may feel embarrassed by a flare-up, especially after a difficult school day. Ask before calling attention to symptoms. Let them help decide what support they want.

For adults, home support may include rest after work, fewer sensory demands, help with tasks that become harder during a flare and a plan for pain or safety. A partner or family member can support without taking control of every symptom.

Reducing pressure without overcontrol

It can be tempting to search for the exact reason a flare-up started. Sometimes you will find a pattern. Sometimes you will not. Tracking should guide care, not blame the person.

A balanced approach can help.

  • Track enough to see patterns
  • Avoid counting every tic all day
  • Do not punish symptoms
  • Avoid forcing long suppression
  • Keep school and work plans practical
  • Ask for care when pain or disruption appears
  • Treat related anxiety, ADHD, OCD or sleep problems when present

The aim is to lower strain while keeping life as normal as possible. If a child tics more before an exciting event, that does not mean the event should always be canceled. It may mean the child needs extra time, a break plan or lower adult attention around the tic.

If an adult tics more during meetings, that does not mean every meeting should be avoided. It may mean the person needs breaks, written follow up, seating choice or treatment support.

Tracking a tic flare-up

Tracking can help your clinician see what changed. Keep notes brief and practical. One or two weeks of notes can be enough unless symptoms are severe.

Track the following.

  • Main tics during the flare-up
  • Date the increase began
  • Motor tics and vocal tics
  • Pain, injury or fatigue
  • Sleep changes
  • Illness or body discomfort
  • Stress or excitement
  • School or work demands
  • Attempts to suppress tics
  • Medication or dose changes
  • ADHD, OCD, anxiety or mood changes
  • Safety concerns

For children, parents can track quietly. Do not point out every tic. Ask about pain, teasing, fatigue and school problems instead.

For teens, ask before recording symptoms. They should help decide what gets shared with a clinician or school. For adults, focus on function. Note if tics affect driving, work, sleep, pain, public settings or relationships.

A short video may help if the person agrees. Tics may not happen during a care visit. Respect privacy and delete videos that are no longer needed.

Urgent warning signs to take seriously

Most tic flare-ups can be handled with monitoring, lower pressure and a care visit when needed. Some changes need prompt medical review.

Seek urgent care or prompt clinical guidance when tics or tic like symptoms come with the following.

  • Loss of awareness
  • Confusion
  • Fainting
  • Seizure like events
  • New weakness
  • Trouble breathing
  • Trouble eating or drinking
  • Severe headache
  • Fever with abnormal movements
  • Chest pain
  • Serious injury
  • Self hitting or self harm risk
  • Sudden severe change after medication or substance exposure
  • New symptoms beginning suddenly in adulthood
  • Suicidal thoughts or immediate danger

These signs may point to issues that need medical assessment. A clinician can review if symptoms fit a tic disorder pattern or another medical concern.

If there is immediate danger, use local emergency services. For suicidal thoughts or self harm risk, seek urgent mental health support through local emergency or crisis resources.

Care team discussion points

A care team can help when flare-ups are painful, disruptive, sudden, frequent or linked with related symptoms. Your care team may include a primary care clinician, pediatrician, neurologist, psychologist, psychiatrist, therapist, school staff, occupational therapist or physical therapist.

Bring clear notes. Tell the clinician what changed, when it began and how it affects daily life. Include pain, injury, school problems, work limits, social stress, sleep changes, illness, medication changes and related symptoms.

Questions to ask can include the following.

  • Does this flare-up fit a typical tic pattern
  • Are any warning signs present
  • Could illness, sleep or pain be contributing
  • Could medication changes play a role
  • Is CBIT appropriate
  • Should medication be reviewed
  • Should ADHD, OCD, anxiety or mood symptoms be assessed
  • What school or work support is appropriate
  • When should follow up happen

The American Academy of Neurology (AAN) guideline includes watchful waiting when tics do not cause functional limits, pain, emotional distress or social embarrassment, and it supports behavioral treatment options such as CBIT when care is needed. The AAN guideline page states that its tic treatment guideline was reaffirmed on April 7, 2025. (American Academy of Neurology)

Links to triggers and treatment

If flare-ups seem connected to daily patterns, read a tic triggers guide. That page should cover stress, fatigue, excitement, illness, school demands, work demands and tracking without blame.

If symptoms are affecting daily life, read a Tourette syndrome treatment guide. That page should cover CBIT, medication, school support, adult care, related conditions and clinician questions.

If you are still sorting out symptoms, read a Tourette syndrome symptoms guide. That page should explain motor tics, vocal tics, simple tics, complex tics, premonitory urges and changes over time.

If the main concern is how to respond day by day, read a managing tics guide. That page should focus on home, school, work, public settings, family communication and reducing shame.

Research context

Research on tic flare-ups can help clinicians learn how sleep, stress, illness, attention, pain and environment affect symptoms. Better research can also improve behavioral care, school support and treatment planning for children, teens and adults.

Regulated psychedelic research has added scientific work on brain networks, emotion processing and therapeutic models. Psilocybin is not an established treatment for tic flare-ups, Tourette syndrome or tic disorders. Any future research in this area should use clear diagnosis, validated tic measures, careful safety review and screening for ADHD, OCD, anxiety and mood symptoms.

Research note

As you review tic flare-ups, symptom changes and future research questions, we at Rose Hill Life Sciences approach this topic through science led education. Our work focuses on psychedelic research, production and study of Psilocybe cubensis, the intersection of science and therapeutic integration and our Massachusetts research work, while tic flare-up evaluation and treatment decisions should remain with qualified healthcare professionals.

Conclusion

Start by reducing pressure around the flare-up. Check for pain, injury, sleep loss, illness, school demands, work demands and recent medication changes. Track the pattern briefly without calling attention to every tic.

If tics are mild and settle, ask a clinician about monitoring at the next routine visit. If tics cause pain, injury, school problems, work problems, major distress or social strain, schedule a care visit.

Seek prompt care for sudden severe changes, loss of awareness, confusion, weakness, breathing problems, fever with abnormal movements, serious injury, self harm risk or symptoms that begin suddenly in adulthood.

A flare-up can be part of the normal tic pattern. A calm plan can help you respond without blame and know when care is needed.

Disclaimer: The information in this article is for educational and informational purposes only and does not constitute medical advice.

You May Also Like

Adam Goodman

Advisor

Adam is a seasoned entrepreneur with a wealth of experience in spearheading real estate development and management endeavors. His focus primarily lies in land development, where he orchestrates the intricate tapestry of planning and zoning entitlements, while meticulously overseeing all facets of engineering and architectural design, leasing, construction, and financing.

With a national reach spanning 23 states and encompassing over 250 properties, totaling more than 6 million square feet, Adam’s proficiency in navigating the complexities of the industry is evident.

Beyond real estate, Adam’s endeavors extend into the realm of alternative investments, boasting successful ventures in healthcare, professional sports franchises, financial services, diverse agricultural platforms, and the stewardship of local restaurants.

 

Rotem Petranker, PhD, Psychology

Psychedelic Researcher

Rotem Petranker is a psychedelics researcher with a particular emphasis on microdosing, therapy, research methods and research ethics. He earned his BSc from the University of Toronto, his Master’s degree from York University, and his PhD from McMaster University.

As part of my research, I have gained extensive expertise in navigating the regulatory landscapes of Health Canada and the FDA and a strong background in designing rigorous clinical trial research methodologies. 

I founded the Canadian Centre for Psychedelic Science in 2018, established the Psychedelic Science Research Program at the University of Toronto in 2019, and, more recently, ran the largest clinical trial to date on the effectiveness of microdosing psilocybin for Major Depressive Disorders. I have published many papers on microdosing, including some of the largest samples in the literature and some that have set standards for performing psychedelic research.

Kevin Bourke

Chief Commercial Officer

Kevin Bourke is a dynamic executive and strategic planner whose career spans over two decades of crafting and elevating world-class Jamaican brands and transformational experiences on the global stage. With a keen understanding of culture, identity, and international markets, he has played a pivotal role in shaping some of Jamaica’s most iconic names — including Appleton Estate Rum, Chris Blackwell’s Rum, and Usain Bolt’s Tracks & Records — bringing them from local roots to international acclaim. His leadership and vision have also been instrumental in major cultural movements such as Fiction and the internationally recognized TmrwTday Wellness Festival.

An innovator at heart, Mr. Bourke seamlessly blends brand strategy with deep cultural resonance. His ability to connect with diverse audiences has established these brands not only as commercial successes but as symbolic ambassadors of Jamaican excellence, fortifying the island’s influence in beverage, music, lifestyle, and experiential sectors.

In recent years, Kevin has steered his strategic acumen toward the cutting-edge psilocybin and wellness industry, becoming a co-founder and Chief Marketing and Branding Officer of Rose Hill, Jamaica’s leading cultivator, exporter, and innovator of psilocybin products and experiences. Through ventures like ONE Retreats, he has helped craft safe, guided psychedelic-assisted healing programs that attract participants from around the world seeking deep personal transformation, including military veterans and international wellness seekers.

Kevin’s impact extends beyond business into industry shaping and policy, as he sits on the Jamaica Psilocybin Mushroom Industry Technical Committee (under the Bureau of Standards) — a pivotal body that is formalizing guidelines and regulatory standards for the emerging legal psilocybin sector in Jamaica. His presence on this committee underscores his leadership role in ensuring the industry’s integrity, safety, and sustainable growth.

Highly regarded for his extensive network throughout Jamaica and internationally, Kevin remains passionately committed to advancing ethical, high-integrity product development and customer-centric experiences at every level. His dedication is driven not only by professional achievement but by a deep vision for human well-being, cultural celebration, and the global evolution of plant-based healing.

Jama Pitman

Regulatory Strategy

Jama Pitman is a seasoned biopharmaceutical executive with extensive expertise in global drug development and commercialization. With over two decades of experience, she has contributed to the development of groundbreaking therapies across oncology, rare diseases, and antivirals. As a strategic leader, she has successfully transitioned companies from private to public markets, navigated complex M&A transactions, and driven innovative drug approvals.

Jama has held executive roles in leading organizations, including Deciphera Pharmaceuticals, where she played a pivotal role in scaling operations from a small, privately held biotech company to a global, multi-product company acquired for $2.4 billion. She brings exceptional skills in regulatory affairs, portfolio management, quality assurance, and clinical operations, longside a proven track record of fostering inclusivity and mentorship within her teams.

Currently, as the founder of JP BioPharma Consulting, Jama advises biopharma and tech companies on accelerating drug development and achieving corporate goals. Her collaborative and forward-thinking approach aligns seamlessly with Rose Hill’s mission to advance transformative therapies in mental health and beyond.

Education: B.Sc. in Microbiology, University of New Hampshire.

Notable Achievements: Contributed to the development of multiple FDA-approved therapies, including QINLOCK® for gastrointestinal stromal tumors.

Domenic Suppa

Chief Operating Officer

Domenic is co-founder and the Operations Chief of Rose Hill Health Holdings.

He has been working as a Cannabis technology and operations veteran with more than 11 years’ experience as a senior executive in an operationally complex, and highly regulated industry.

His introduction and entrance into the Cannabis sector started in 2010 with a seed investment into a Denver-based vertically integrated cannabis company called, Evolab. He served as C.O.O. for 5 years from 2013-2018, through the eventual acquisition by Harvest Health and Recreation (HARV: CSE).

Domenic moved on to be acting COO of the manufacturing division for Supreme Cannabis (CSE: FIRE) and supported the acquisition of BLISSCO (CSE: BLISS, a BC-based cannabis manufacturer). Domenic has worked with high-profile national cannabis brands including KKE, and Monogram, and retail brands in MA Native Sun, Terps, and Tilt. Domenic is a proven leader and team builder; his previous experiences have all been with early-stage and growth equity enterprises.

He has refined and evolved his leadership roles, including his team-building skills. He is a value creator. Domenic is a firm believer in training and continuous development. He excels in employing practices, tools, and methodologies designed to achieve maximum process efficiency while minimizing waste and delays.

 

Burton J. Tabaac

Clinical Development

Dr. Burton J. Tabaac, MD, FAHA, brings a wealth of expertise in neurology and stroke rehabilitation to Rose Hill. As an Associate Professor and Section Chief of Neurology at The University of Nevada’s Reno School of Medicine, and Medical Director of Stroke at Carson Tahoe Health, Dr. Tabaac has been at the forefront of innovative neurological treatments.

A graduate of the prestigious cerebrovascular neurology fellowship program at The Johns Hopkins University Hospital, Dr. Tabaac’s accolades include being a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award and induction into the Alpha Omega Alpha Honor Medical Society.

He recently published an eight-part paper in the American Journal of Therapeutics reviewing psychedelics as therapeutics for primary care clinicians. Dr. Tabaac’s groundbreaking research focuses on the application of psychedelics in brain injury and stroke rehabilitation.

Dr. Tabaac was recently appointed by the Governor of Nevada to serve as a member of the state’s Psychedelic Medicines Working Group, which provides expertise and testimony relating to the therapeutic use of entheogens.

As the host of The Zero Hour Podcast, he engages with leading experts in psychedelic research. His commitment to advancing the field was further highlighted in his 2022 TEDx talk at UCLA, “Mental Health Meets Psychedelics.”

“Joining Rose Hill’s advisory team presents an exciting opportunity to further explore the potential of psilocybin in neurological recovery,” said Dr. Tabaac.

“The company’s commitment to ethical cultivation and research aligns perfectly with my vision for advancing patient care through innovative therapies. I’m eager to bring my expertise to Rose Hill and contribute to the evolving landscape of psychedelic medicine.”

Charles Lazarus

Chief Executive Office

Mr. Lazarus boasts over 16 years of extensive expertise in psilocybin and cannabis, focusing on genetic development, cultivation, extraction, and operations logistics. Notably, he recently achieved a milestone by cultivating and delivering the largest legal shipment of premium psilocybin globally.

As an accomplished owner/operator, Mr. Lazarus has successfully managed multiple farming and harvesting businesses, earning commendations for his unwavering commitment to quality and impressive output volumes. Since 2015, he has been actively involved in producing proprietary psilocybin genetics and cultivation solutions tailored for the Jamaican market and large research and development clients.

His contributions span various aspects, including genetic development, cultivation, extraction, harvest, and logistics. Additionally, Mr. Lazarus owned and operated Island Fresh Ltd., a venture that played a pivotal role in exporting fresh fruit, ground provisions, and promoting brand Jamaica to the English market. Under his leadership, Island Fresh Ltd. achieved the highest volume from Jamaica for three consecutive years.

Mr. Lazarus’s extensive experience also includes serving as the Harvest Manager for cannabis grow operations in California from 2013 to 2017, further solidifying his comprehensive knowledge in the cannabis industry.